Proton pump inhibitors alter the composition of the gut microbiota

Articles citing Proton pump inhibitors alter the composition of the gut microbiota

Title / Author	Year
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, ... Science 359 (6371), 91-97	2018
Extensive impact of non-antibiotic drugs on human gut bacteria L Maier, M Pruteanu, M Kuhn, G Zeller, A Telzerow, EE Anderson, ... Nature 555 (7698), 623-628	2018
Genetic determinants of the gut microbiome in UK twins JK Goodrich, ER Davenport, M Beaumont, MA Jackson, R Knight, C Ober, ... Cell host & microbe 19 (5), 731-743	2016
Best practices for analysing microbiomes R Knight, A Vrbanac, BC Taylor, A Aksenov, C Callewaert, J Debelius, ... Nature Reviews Microbiology 16 (7), 410-422	2018
Human gut microbiome: hopes, threats and promises PD Cani Gut 67 (9), 1716-1725	2018
Role of the gut microbiota in nutrition and health AM Valdes, J Walter, E Segal, TD Spector Bmj 361	2018
The gut microbiome in atherosclerotic cardiovascular disease Z Jie, H Xia, SL Zhong, Q Feng, S Li, S Liang, H Zhong, Z Liu, Y Gao, ... Nature communications 8 (1), 1-12	2017
Complications of proton pump inhibitor therapy MF Vaezi, YX Yang, CW Howden Gastroenterology 153 (1), 35-48	2017
Gut microbiome interactions with drug metabolism, efficacy, and toxicity ID Wilson, JK Nicholson Translational Research 179, 204-222	2017
The gut–liver axis and the intersection with the microbiome A Tripathi, J Debelius, DA Brenner, M Karin, R Loomba, B Schnabl, ... Nature reviews Gastroenterology & hepatology 15 (7), 397-411	2018
Microbiota-brain-gut axis and neurodegenerative diseases EMM Quigley Current neurology and neuroscience reports 17 (12), 94	2017
Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain C Menni, MA Jackson, T Pallister, CJ Steves, TD Spector, AM Valdes International Journal of Obesity 41 (7), 1099-1105	2017
Gut microbiota associations with common diseases and prescription medications in a population-based cohort MA Jackson, S Verdi, ME Maxan, CM Shin, J Zierer, RCE Bowyer, ... Nature communications 9 (1), 1-8	2018
Heritable components of the human fecal microbiome are associated with visceral fat M Beaumont, JK Goodrich, MA Jackson, I Yet, ER Davenport, ... Genome biology 17 (1), 1-19	2016
Functional dyspepsia NJ Talley, DR Cook Essential Medical Disorders of the Stomach and Small Intestine, 155-172	2019
Proton pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a population study CF Tsai, MH Chen, YP Wang, CJ Chu, YH Huang, HC Lin, MC Hou, ... Gastroenterology 152 (1), 134-141	2017
Association of gastric acid suppression with recurrent Clostridium difficile infection: a systematic review and meta-analysis R Tariq, S Singh, A Gupta, DS Pardi, S Khanna JAMA internal medicine 177 (6), 784-791	2017
Dyspepsia and the microbiome: time to focus on the small intestine L Zhong, ER Shanahan, A Raj, NA Koloski, L Fletcher, M Morrison, ... Gut 66 (6), 1168-1169	2017
Proton-pump inhibitors: understanding the complications and risks P Malfertheiner, A Kandulski, M Venerito Nature Reviews Gastroenterology & Hepatology 14 (12), 697-710	2017
Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications Q Le Bastard, GA Al‐Ghalith, M Grégoire, G Chapelet, F Javaudin, ... Alimentary Pharmacology & Therapeutics 47 (3), 332-345	2018

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.